ABSTRACT
The circular economy can help enhance the value of industrial waste and remediate the environment. This study considers the application of iron scrap from steel production as a free resource to produce magnetic adsorbent beads to remove methylene blue dye and lead (II) ions from wastewater. Composite beads were prepared by incorporating iron scrap and activated carbon into a calcium alginate gel using a simple 'mix and drop' synthesis. The optimized magnetic beads were stable and offered a large specific surface area. The maximum adsorption capacity of the adsorbent, calculated from the Langmuir isotherm model, was 476.19 mg g-1 for methylene blue and 163.93 mg g-1 for lead (II) ions. This study places emphasis upon the zero-waste principle and employs a scalable synthetic approach for the conversion of waste iron scrap into an adsorbent material capable of delivering significant environmental benefits.
Subject(s)
Metals, Heavy , Water Pollutants, Chemical , Iron , Alginates , Methylene Blue , Adsorption , Magnetic Phenomena , Ions , Textiles , Kinetics , Hydrogen-Ion ConcentrationABSTRACT
Nanoparticle (NP)-based contrast agents that enable high resolution anatomic T1-weighted magnetic resonance imaging (MRI) offer the prospect of improving differential diagnosis of liver tumors such as hepatocellular carcinoma (HCC). In the present study, we investigated the possibility of employing novel non-toxic human serum albumin nanoparticles conjugated with Gd-DTPA and rhodamine 123 (Gd-Rho-HSA-NPs) for the detection of HCC by T1-weighted MRI. In addition, the influence of surface coating of the NPs with poloxamine 908, which alters the absorptive behavior of NPs and changes their distribution between the liver and tumor was examined. MRI of transgenic mice with endogenously formed HCCs following intravenous injection of Gd-Rho-HSA-NPs revealed a strong negative contrast of the tumors. Contrasting of the HCCs by NP-enhanced MRI required less Gd as compared to gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid-enhanced MRI, which currently provides the most sensitive detection of HCC in patients. Immunohistochemical analyses revealed that the Gd-Rho-HSA-NPs were localized to macrophages, which were - similar to HCC in patients - fewer in number in HCC as compared to the liver tissue, which is in agreement with the negative contrasting of HCC in Gd-Rho-HSA-NP-enhanced MRI. Poloxamine-coated NPs showed lower accumulation in the tumor macrophages and caused a longer lasting enhancement of the MRI signal. These data indicate that Gd-Rho-HSA-NPs enable sensitive detection of HCC by T1-weighted MRI in mice with endogenous HCC through their uptake by macrophages. Poloxamine coating of the NPs delayed the tumor localization of the NPs.
Subject(s)
Carcinoma, Hepatocellular/diagnosis , Contrast Media , Gadolinium DTPA , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Rhodamine 123 , Serum Albumin , Animals , Carcinoma, Hepatocellular/pathology , Cell Survival/drug effects , Ethylenediamines , Excipients , Genes, myc/genetics , Humans , Liver/pathology , Liver Neoplasms/pathology , Macrophages, Peritoneal/drug effects , Mice , Mice, Transgenic , Nanoparticles , Particle Size , Polyethylene Glycols , Tissue Distribution , Transforming Growth Factor alpha/geneticsABSTRACT
Tumor visualization by magnetic resonance imaging (MRI) and nanoparticle-based contrast agents may improve the imaging of solid tumors such as hepatocellular carcinoma (HCC). In particular, human serum albumin (HSA) nanoparticles appear to be a suitable carrier due to their safety and feasibility of functionalization. In the present study HSA nanoparticles were conjugated with gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) using carbodiimide chemistry. The nanoparticles had a uniform spherical shape and a diameter of 235±19nm. For better optical visualization in vitro and in vivo, the HSA-Gd nanoparticles were additionally labeled with rhodamine 123. As shown by confocal microscopy and flow cytometry analysis, the fluorescent nanoparticles were readily taken up by Huh-7 hepatocellular carcinoma cells. After 24h incubation in blood serum, less than 5% of the Gd(III) was released from the particles, which suggests that this nanoparticulate system may be stable in vivo and, therefore, may serve as potentially safe T1 MRI contrast agent for MRI of hepatocellular carcinoma.
Subject(s)
Albumins/chemistry , Biocompatible Materials/chemistry , Carcinoma, Hepatocellular/diagnosis , Contrast Media/chemistry , Gadolinium DTPA/chemistry , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging , Nanoparticles/chemistry , Albumins/pharmacokinetics , Animals , Biocompatible Materials/adverse effects , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Cell Survival/drug effects , Contrast Media/adverse effects , Gadolinium DTPA/pharmacokinetics , Humans , Liver Neoplasms/pathology , Liver Neoplasms, Experimental/diagnosis , Liver Neoplasms, Experimental/pathology , Mice , Mice, Transgenic , Nanoparticles/adverse effects , Particle Size , Serum Albumin/chemistry , Surface PropertiesABSTRACT
PURPOSE: In this study, the contrasting properties of human serum albumin nanoparticles (HSA-NPs) loaded with gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) and coated with transferrin in MRI in mice are evaluated. PROCEDURES: HSA-NPs were conjugated with Gd-DTPA (Gd-HSA-NPs) and coupled with transferrin (Gd-HSA-NP-Tf). Mice underwent MRI before or after injection of Gd-DTPA, Gd-HSA-NP, or Gd-HSA-NP-Tf. RESULTS: All the studied contrast agents provided a contrast enhancement (CE) in the blood, heart muscle, and liver. Compared to Gd-DTPA, CE with HSA-NP was achieved at lower Gd doses. Gd-HSA-NP-Tf yielded significantly higher CE than Gd-HSA-NP in the skeletal muscle, blood, cardiac muscle, and liver (p < 0.05). Gd-HSA-NP-Tf achieved a significantly higher CE than Gd-HSA-NP and Gd-DTPA in the blood, cardiac muscle, and liver (p < 0.05). In the brain, only Gd-HSA-NP-Tf was found to cause a significant CE (p < 0.05). CONCLUSIONS: The Gd-HSA nanoparticles have potential as MRI contrast agents. In particular, Gd-HSA-NP-Tf has a potential as a specific contrast agent for the brain, while the blood-brain barrier is still intact, as well as in the heart, liver, and skeletal muscle.